Clinical trial
Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative…
NCT00282555 · STEBA France, Industry · Suspended
Key facts
| NCT number | NCT00282555 |
|---|---|
| Title | Efficiency Study of S-Tenatoprazole-Na to Treat Erosive or Ulcerative Esophagitis |
| Official title | Assessment of the Healing Rate of Erosive or Ulcerative Esophagitis After Two and Four Weeks of Treatment With S-Tenatoprazole-Na (STU-Na) 15 mg, 30 mg, 60 mg, 90 mg and Esomeprazole 40 mg. A Multicenter, Randomized, Double-Blind, Parallel Group Study. |
| Lead sponsor | STEBA France, Industry |
| Status | Suspended |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Esophagitis, Reflux |
| Intervention type | Drug |
| Interventions | S-Tenatoprazole-Na (STU-Na) |
| Enrollment | 450 |
| Start date | Feb 1, 2006 |
| First posted | Jan 26, 2006 |
| Last update posted | Mar 19, 2008 |
| Countries | Canada |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: